Key result
Slow pathway ablation eliminates dual AV nodal nonreentrant tachycardia and normalizes LVEF from baseline ~21%.
Why the study?
Dual atrioventricular nodal nonreentrant tachycardia is a rare, often underestimated supraventricular tachycardia that frequently goes unnoticed by the patient and can cause tachycardiomyopathy.
Does radiofrequency slow pathway ablation resolve tachycardia-induced cardiomyopathy in a patient with dual atrioventricular nodal nonreentrant tachycardia?
Case Report (n=1)
No
Does radiofrequency slow pathway ablation resolve tachycardia-induced cardiomyopathy in a patient with dual atrioventricular nodal nonreentrant tachycardia?
Dual atrioventricular nodal nonreentrant tachycardia (DAVNNT) is an underrecognized cause of reversible tachycardia-induced cardiomyopathy that can be cured with slow pathway radiofrequency ablation.
Answers are grounded in this paper and cite their sources.
May reverse DAVNNT cardiomyopathy after slow pathway ablation; hypothesis-generating pending prospective studies.
Dual atrioventricular nodal nonreentrant tachycardia (DAVNNT) is a rare form of supraventricular tachycardia. In some patients, the presence of a dual pathway physiology results in two paths in the atrioventricular (AV) node with different conduction velocities. An atrial impulse arriving at the AV node may unfold and travel along these two pathways simultaneously, causing two ventricular activations. Thus, the ventricular rate will be twice the atrial rate. DAVNNT is less common than AVNRT, but its frequency may be underestimated. The ECG is crucial to suspect the diagnosis. At first glance it looks like an irregular tachycardia, but a more careful look shows a rhythmic pattern. A sinus P wave followed by two QRS complexes (narrow or wide) should raise suspicion of this arrhythmia. It is often unnoticed by the patient, and ventricular dysfunction due to tachycardiomyopathy is not uncommon. The response of DAVNNT to medication, including beta-blockers, flecainide, and amiodarone is very poor or absent, so the treatment of choice is slow pathway ablation. We report a Case of cardiomyopathy caused by this entity.
No takes yet. Share an insight, caveat, or question.
Bares et al. (2021) conducted a case report in Dual atrioventricular nodal nonreentrant tachycardia (DAVNNT)-induced cardiomyopathy (n=1). Radiofrequency slow pathway ablation was evaluated on Resolution of tachycardia and normalization of biventricular ejection fraction and chamber size at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: